Bidgood, SR;
(2019)
Continued poxvirus research: From foe to friend.
PLOS Biology
, 17
(1)
, Article e3000124. 10.1371/journal.pbio.3000124.
Preview |
Text
journal.pbio.3000124.pdf - Published Version Download (452kB) | Preview |
Abstract
The eradication of smallpox is one of the greatest medical successes in history. Vaccinia virus was made famous by being the virus used in the live vaccine that enabled this feat. Nearly 40 years on from that success, this prototypical poxvirus continues to empower the exploration of fundamental biology and the potential to develop therapeutics against some of the major causes of death and disease in the modern world.
| Type: | Article |
|---|---|
| Title: | Continued poxvirus research: From foe to friend |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1371/journal.pbio.3000124 |
| Publisher version: | https://doi.org/10.1371/journal.pbio.3000124 |
| Language: | English |
| Additional information: | Copyright © 2019 Susanna R. Bidgood. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| Keywords: | Vaccinia virus, Smallpox virus, Ebola virus, Smallpox, Virions, Cell biology, Vaccination and immunization, Viral vaccines |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Lab for Molecular Cell Bio MRC-UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10075537 |
Archive Staff Only
 |
View Item |
